The present invention relates to compounds of general formula I,
wherein the groups (Het)Ar and R
1
are defined as in claim
1
, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.
The present invention provides cyclic depsipeptide compounds of formula (I) and compositions comprising the compounds that are effective against parasites that harm animals. The compounds and compositions may be used for combating parasites in or on mammals and birds. The invention also provides for an improved method for eradicating, controlling and preventing parasite infestation in birds and mammals.
[EN] DICHROIC AZO-AZOMETHINE DYES FOR LIQUID CRYSTAL COMPOSITIONS<br/>[FR] COLORANTS DICHROÏQUES D'AZO-AZOMÉTHINE POUR COMPOSITIONS À CRISTAUX LIQUIDES
申请人:BASF SE
公开号:WO2020156832A1
公开(公告)日:2020-08-06
Dichroic azo-azomethine dyes of formula (A) or (B), wherein Ar1 to Ar10 are specific (hetero)aromatic moieties and L is a linking group, as defined in the present claims, a dichroic dye mixture comprising said azo-azomethine dyes and a process for preparing the dyes are provided. The dyes are well suited for combination with liquid crystal material for use, inter alia, in a light absorption anisotropic element, for example,in a switchable optical device or an optically anisotropic film.
[EN] HETEROCYCLIC SUBSTITUTED UREAS, FOR USE AGAINST CANCER<br/>[FR] URÉES SUBSTITUÉES HÉTÉROCYCLIQUES, DESTINÉES À ÊTRE UTILISÉES CONTRE LE CANCER
申请人:ARTIOS PHARMA LTD
公开号:WO2020030925A1
公开(公告)日:2020-02-13
The application relates to heterocyclic urea derivatives and their use in the treatment and prophylaxis of cancer, and to compositions containing said derivatives and processes for their preparation.